Related Experiment Video
Updated: Mar 10, 2026
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Effects of oncostatin M on cell proliferation and osteogenic differentiation in C3H10T1/2
1Department of Orthopeadics, Xiangyang Hospital, Hubei University of Medicine, Xiangyang, Hubei Province, 441001, China.
Objective:
To explore the effects of protein factor Oncostatin M (OSM), a member of the Interleukin-6 (IL-6) family on cell proliferation, osteogenic differentiation and mineralization.
Materials And Methods:
Basal nutrient solutions of different concentrations of OSM (0, 5, 10, 20, 40, 80 ng/ml) were used. In order to divide embryonic origin between mesenchymal stem cells C3H10T1/2 of in vitro cultured mice, and the effects of in vitro proliferation efficiencies of C3H10T1/2 cells of different concentrations of OSM, the C3H10T1/2 cells were divided into four groups: (1) Basal nutrient solution group (negative control); (2) Osteogenesis induced liquid group (positive control); (3) OSM (20 ng/ml) group; (4) Experimental group (osteogenesis induced liquid + OSM (20 ng/ml)). The expressions levels of relevant osteogenesis and mineralization genes were detected.
Results:
OSM had several effects on promoting the proliferation of embryonic origin mesenchymal stem cells C3H10T1/2 with respect to time of exposure as well as concentrations. In the present study, it has been shown that when the concentration of OSM is 20 ng/ml, the effects of promoting proliferation are most obvious. OSM can induce osteogenic differentiation of C3H10T1/2, make the process of osteogenic differentiation in advance, and promote the formation of end-stage calcium deposits and mineralized nodule, and osteogenic differentiation of C3H10T1/2 is finally achieved.
Conclusion:
OSM can promote the proliferation of C3H10T1/2, and induce its osteogenic differentiation and end-stage mineralization.
Insights
Oncostatin M (OSM) promotes the proliferation of mesenchymal stem cells. This protein factor also induces osteogenic differentiation and enhances mineralization, crucial for bone formation.
Area of Science:
- Biochemistry and Molecular Biology
- Stem Cell Biology
- Bone Biology
Background:
- Oncostatin M (OSM) is a cytokine belonging to the Interleukin-6 (IL-6) family.
- Mesenchymal stem cells (MSCs) are multipotent cells with the capacity for osteogenic differentiation.
- Understanding factors that regulate MSCs is critical for regenerative medicine and bone tissue engineering.
Purpose of the Study:
- To investigate the impact of Oncostatin M (OSM) on the proliferation of mouse embryonic mesenchymal stem cells (C3H10T1/2).
- To determine OSM's role in inducing and regulating osteogenic differentiation and mineralization of C3H10T1/2 cells.
- To identify optimal concentrations of OSM for promoting these cellular processes.
Main Methods:
- In vitro culture of C3H10T1/2 cells.
- Treatment with varying concentrations of OSM (0-80 ng/ml) and osteogenic induction media.
- Assessment of cell proliferation, osteogenic gene expression, and mineralization nodule formation.
Main Results:
- OSM significantly promoted the proliferation of C3H10T1/2 cells in a dose- and time-dependent manner.
- A concentration of 20 ng/ml OSM demonstrated the most pronounced proliferative effects.
- OSM effectively induced osteogenic differentiation and accelerated the formation of mineralized nodules.
Conclusions:
- Oncostatin M (OSM) is a potent stimulator of mesenchymal stem cell proliferation.
- OSM actively induces osteogenic differentiation and promotes end-stage mineralization in C3H10T1/2 cells.
- These findings highlight OSM's potential therapeutic role in bone regeneration and related disorders.
